 |
||||||||
|
Click Here to join James B. Groce III, PharmD, CACP
Time: Thursday, January 30th, 2008 from 6:30pm until 7:30pm "Ask the Experts" Program Description: This live question and answer session will provide you the opportunity to ask nationally recognized experts in the area of venous thromboembolic disease about current issues related to VTE. Our esteemed faculty will provide their succinct insight to address contemporary concerns practitioners may have regarding the management of VTE in an interactive environment. Topics open for discussion include the under-utilization of VTE prophylaxis, preventing, diagnosing, and treating VTE in hospitalized patients, as well as the management of VTE in patients with cancer. Original Program Launch Date: September 26, 2007 Original Program Description: This case-based educational program will help you to identify and discuss pertinent clinical data for the treatment and prevention of VTE, as well as demonstrate how these data can be interpreted and applied into clinical practice. This would include discussion of current issues and controversies surrounding management of VTE, identifying risk factors for VTE, the treatment and secondary prophylaxis in VTE, treatment options for the management of acute PE, as well a special consideration for the medically ill or patients with comorbidities. By reviewing specific patient cases, our esteemed faculty will provide concise and contemporary insight addressing concerns practitioners have regarding the management of patients with VTE. Target Audience: This activity is designed to meet the educational needs of Cardio-thoracic Surgeons, Clinical Cardiologists, Primary Care Physicians, Internal Medicine Physicians, Interventional Cardiologists, Pulmonary Medicine Physicians and Nurses. Educational Objectives: Upon completion of this educational activity participants will be able to:
Disclosure Policy It is the policy of ArcMesa Educators to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty/authors are expected to disclose any relevant financial relationships they may have with commercial interests in relation to this activity. These relationships, along with the educational content of this program, have been reviewed and any potential conflicts of interest have been resolved to the satisfaction of ArcMesa Educators. Faculty Disclosure Declarations Samuel Goldhaber, MD Staff Disclosure Declarations The employees of ArcMesa Educators have no financial relationships to disclose. Accreditation ArcMesa Educators is accredited by the ACCME to provide continuing medical education for physicians. ArcMesa Educators designates this educational activity for a maximum of 2 AMA PRA Category 1 credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. ArcMesa Educators is an approved provider of continuing education in nursing by ASNA, an accredited approver by the ANCC Commission on Accreditation. (ANCC AL #5-85). ArcMesa is an approved provider by the Florida Board of Nursing (#FBN2002). Disclaimer ©2007 ArcMesa Educators, LLC / CMEdiscovery.com. All rights reserved. None of the contents may be reproduced in any form without prior written permission from ArcMesa Educators, LLC. The views and opinions expressed in this activity are those of the faculty. They do not reflect the views of Sanofi-Aventis, any other manufacturer of pharmaceuticals, or ArcMesa Educators. The recommendations made in this program are based upon a combination of randomized clinical trials, current guidelines, and the clinical practice experience of the participating panelists. Any medications, diagnostic procedures or treatments discussed by the panelists should not be utilized without evaluation of their patient's conditions. Participants are urged to consult the full prescribing information on any drug mentioned in this activity for recommended dosage, indications, contraindications, warnings, precautions, and adverse effects before prescribing any medication.
|
|
 |
|